We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
30/8/2022 17:37 | would be nice to add more at a lower price | supermarky | |
30/8/2022 15:20 | Need a drop to 12-13 pounds to buy some more ? | abdullla | |
30/8/2022 12:58 | ADR's now equiv. £14.29 at pre-market. | cyberian | |
30/8/2022 12:55 | Will take time to filter through , expecting it to be at £15 within next couple of weeks | alibizzle | |
30/8/2022 10:02 | Its interesting, no good news, the falling pound, promising drugs, even the interesting news re: litigations is making this share rise. The market is in denial and wants to be depressed and no amount of cheerfulness will make the depressed UK investor feel happy. | netcurtains | |
30/8/2022 09:29 | WS pre-opening ADR price for GSK currently equiv. £14.22, so helpful? | cyberian | |
30/8/2022 08:32 | 1410 currently so all good. I think it was an opening reaction to the US. | tuftymatt | |
30/8/2022 08:20 | spoole5: you could be right but on my screen its up. I guess I'm 20 minutes delayed. How much is it down in real time? | netcurtains | |
30/8/2022 08:04 | And down she goes! Will be vulnerable to an opportunistic bid soon. | spoole5 | |
29/8/2022 23:40 | TM...agree but looking promising. WS adr's after hours were approx. 14.17 equiv.tonight. Still need to be guarded but Citi coverage is a reasonable starter for a more balanced view. The shingles drug doing very well in China plus a few other recent drug releases, and all key Pharmas are critical more than ever to keep us in as good shape as possible health wise. Have recently had a few negative side effects on a problem currently causing some severe discomfort but remain positive despite some expected risks to treatment. Hope the next few days/months secure some more hopeful developments on the energy/economic global scene but there appears to be a more collective effort to get to grips with the near term overriding problem mainly caused by Russia. It may take some times but the direction and pace will quicken and surprise those pushing their luck and deservedly so ...alternatives to fossil fuels and their current concentrations will abate and prices fall accordingly. Keep the faith..... | cyberian | |
29/8/2022 18:03 | I am not surprised as there are still a few more hurdles to cross | tradermichael | |
29/8/2022 16:49 | Interestingly none of the recent court news or drug news is making GSK rise in the USA today (so far). Is that to be expected or are you somewhat surprised? | netcurtains | |
29/8/2022 11:08 | USD 1.17 = £1.00 | tradermichael | |
29/8/2022 11:08 | Yes, I see 1950+ if the market recognises this with a reversal of sentiment .... ;0) | tradermichael | |
29/8/2022 10:56 | TM: That in itself, never mind the potential good news from the courts, might equate to a potential share price rise of about 5 to 6% (eg £2b as a percentage of sales). | netcurtains | |
29/8/2022 10:44 | Could reach over £2 billion in sales by end of 2026. | tradermichael | |
29/8/2022 10:11 | And other news | berny3 | |
29/8/2022 09:28 | All ifs and buts regarding plaintiffs , but here's hoping for share price rise | alibizzle | |
28/8/2022 13:40 | Hi everyone | enochmwepu | |
28/8/2022 13:10 | This is another story on the matter which may help | berny3 | |
28/8/2022 12:58 | Anyone with a view on percentage likelihood that this will happen? | netcurtains | |
28/8/2022 09:04 | Thanks TraderMichael, That's from | zho | |
28/8/2022 08:12 | A recent ruling by a US judge overseeing the lawsuits could mean 70,000 plaintiffs could be forced to abandon their claims due to the statute of limitations, which sets a time limit in which someone is allowed to bring legal action. If that happens, shares in GSK and French rival Sanofi, which also sold Zantac, could surge by over 40 per cent. | tradermichael | |
26/8/2022 22:37 | Agree. Divi is atrocious. Shel have lost alot of trust and were always a good divi stock. Not now it would seem | supermarky |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions